What does CUSIP G6829J107 represent in this 13F holders report?

CUSIP G6829J107 is the security identifier for OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS used to aggregate holder disclosures.

How many institutions held OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS in Q3 2021?

140 institutional investors reported OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS for Q3 2021. Use the holders table for investor-level position and value details.

ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX)

CUSIP: G6829J107

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / ORD SHS
Total 13F shares: 233,369,588
Share change: +1,542,018
Total reported value: $4,313,184,141
Put/Call ratio: 61%
Price per share: $18.48
Number of holders: 140
Value change: +$26,369,910
Number of buys: 108
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP G6829J107?
CUSIP G6829J107 identifies OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP G6829J107:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Institutional Holders of ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) as of Q3 2021

As of 30 Sep 2021, ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 233,369,588 shares. The largest 10 holders included Carlyle Group Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., SHAPIRO CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, LAZARD ASSET MANAGEMENT LLC, Alyeska Investment Group, L.P., and Boston Partners. This page lists 140 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.